Results 51 to 60 of about 210,319 (212)

Telerehabilitation after total knee replacement in Italy: cost-effectiveness and cost-utility analysis of a mixed telerehabilitation-standard rehabilitation programme compared with usual care [PDF]

, 2016
OBJECTIVES: To assess cost-effectiveness and cost utility of telerehabilitation (TR) versus standard rehabilitation (SR) after total knee replacement (TKR).
Fusco, F, TURCHETTI, Giuseppe
core   +1 more source

Cost-effectiveness of chemotherapy in advanced and recurrent endometrial cancer

Gynecologic Oncology Reports
Objective: To review the cost-effectiveness of chemotherapy and immunotherapy-based regimens for advanced and recurrent endometrial cancer, focusing on incremental cost-effectiveness ratios (ICERs).
Katsuaki Inami
doaj   +1 more source

Cost effectiveness of aortic valve therapies: a systematic review of the literature

Epidemiology, Biostatistics and Public Health, 2013
Background: we performed a systematic review on the cost effectiveness of transcatheter aortic valve implantation (TAVI) to standard aortic valve replacement and medical management in high-risk elderly patients with severe aortic stenosis.Methods: in ...
Suzanne Battaglia, Walter Mazzucco, Walter Ricciardi   +2 more
doaj   +1 more source

Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease [PDF]

, 2015
Objective. To estimate the cost-effectiveness of adalimumab plus methotrexate (MTX) versus MTX monotherapy in early, aggressive rheumatoid arthritis (RA) when explicitly modelling short-term (reversible) and long-term (irreversible, ie, joint damage ...
Albers, Aletaha, Aletaha, Breedveld, Castro-Rueda, Davies, Emery, Enbrel [prescribing information], Finckh, Geborek, HUMIRA [prescribing information], Keystone, Klareskog, Kobelt, Krishnan, Lee, Lipsky, Remicade [prescribing information], Saag, Schipper, Simponi [prescribing information], Smolen, Smolen, Sokka, Spalding, St Clair, Tran-Duy, van den Hout, van der Heijde, Van der Kooij, van Vollenhoven, Weinblatt, Wolfe   +32 more
core   +1 more source

Quality-adjusted Life Years and Costs of Mechanical Thrombectomy for Very Elderly Patients with Acute Ischaemic Stroke

Neurologia Medico-Chirurgica
This study aimed to evaluate the cost-effectiveness of mechanical thrombectomy (MT) in patients aged 90 years and older with acute ischaemic stroke (AIS). We developed a cost-effectiveness model to compare MT with standard medical care (SMC) to SMC alone.
Takeshi INABA, Mio SAKUMA, Fumihiro SAKAKIBARA, Kazutaka UCHIDA, Takeshi MORIMOTO   +4 more
doaj   +1 more source

Cost-Effectiveness of Haemorrhoidal Artery Ligation versus Rubber Band Ligation for the Treatment of Grade II–III Haemorrhoids: Analysis Using Evidence from the HubBLe Trial [PDF]

, 2017
Aim Haemorrhoids are a common condition, with nearly 30,000 procedures carried out in England in 2014/15, and result in a significant quality-of-life burden to patients and a financial burden to the healthcare system.
A Manca, AH Briggs, AJM Watson, AR Willan, H Liu, J Burch, JS Hoch, L McKenzie, M Drummond, M Herdman, MS Sajid, P Giordano, P Lehur, PB Loder, PH Pucher, R Faria, S Avital, SR Brown, VS Iyer   +18 more
core   +1 more source

The impact of statistical properties of incremental monetary net benefit and incremental cost-effectiveness ratio on health economic modeling choices

Expert Review of Pharmacoeconomics & Outcomes Research, 2022
There is controversy on whether to use incremental monetary net benefit (INMB) or incremental cost-effectiveness ratio (ICER) in health economic evaluations alongside randomized controlled trials. We studied the impact of restricted mean survival time (RMST) on the long-term projection of INMB and ICER.
Fei Yuan, Shrikant I. Bangdiwala, Wesley Tong, Andre Lamy   +3 more
openaire   +2 more sources

Effectiveness and cost-effectiveness of erlotinib versus gefitinib in first-line treatment of epidermal growth factor receptor-activating mutation-positive non-small-cell lung cancer patients in Hong Kong [PDF]

, 2014
OBJECTIVE: To compare the effectiveness and cost-effectiveness of erlotinib versus gefitinib as first-line treatment of epidermal growth factor receptor-activating mutation-positive non-small-cell lung cancer patients. DESIGN.
Lee, VHF, Lee, VWY, Schwander, B
core   +1 more source

Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology [PDF]

PharmacoEconomics - Open, 2017
Incremental cost-effectiveness ratios (ICERs) are used to assess the value for money of new drugs. Many believe that ICERs for drugs that treat rare diseases are much higher than those of common drugs. Our objective was to compare the proportion of ICERs that are cost effective for rare and common cancers.We used the Tufts Medical Center Cost ...
Kavisha Jayasundara, Murray Krahn, Muhammad Mamdani, Jeffrey S. Hoch, Paul Grootendorst   +4 more
openaire   +4 more sources

Cost-effectiveness of Methadone Maintenance Treatment in prevention of HIV among drug users in Shiraz, south of Iran [PDF]

, 2014
Background: The increase in high-risk injections and unsafe sexual behaviors has led to increased HIV infection prevalence among Intravenous Drug Users (IDUs). The high costs of HIV/AIDS care and low financial resources necessitate an economic evaluation
Heidari, A., Javanbakht, M., Keshtkaran, A., Mirahmadizadeh, A.   +3 more
core   +1 more source